Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer.
Saved in:
| Title: | Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer. |
|---|---|
| Authors: | Kian W; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel., Christopoulos P; Department of Thoracic Oncology, Thoraxklinik at Heidelberg University Hospital, Member of the German Center for Lung Research (DZL), and Translational Lung Research Heidelberg, Heidelberg, Germany., Remilah AA; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel., Levison E; Medical School for International Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Dudnik E; Thoracic Cancer Service, Assuta Medical Centers, Ben-Gurion University, Tel-Aviv, Israel., Shalata W; The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel., Krayim B; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel., Marei R; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel., Yakobson A; The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel., Faehling M; Department of Pneumology, Esslingen Hospital, Esslingen, Germany., Kahala D; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel., Sara Granot I; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel., Levitas D; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel., Peled N; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel., Roisman LC; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel. |
| Source: | Frontiers in oncology [Front Oncol] 2022 Sep 20; Vol. 12, pp. 1010311. Date of Electronic Publication: 2022 Sep 20 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36203432 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kian+W%22">Kian W</searchLink>; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Christopoulos+P%22">Christopoulos P</searchLink>; Department of Thoracic Oncology, Thoraxklinik at Heidelberg University Hospital, Member of the German Center for Lung Research (DZL), and Translational Lung Research Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Remilah+AA%22">Remilah AA</searchLink>; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Levison+E%22">Levison E</searchLink>; Medical School for International Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Dudnik+E%22">Dudnik E</searchLink>; Thoracic Cancer Service, Assuta Medical Centers, Ben-Gurion University, Tel-Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Shalata+W%22">Shalata W</searchLink>; The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Krayim+B%22">Krayim B</searchLink>; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Marei+R%22">Marei R</searchLink>; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Yakobson+A%22">Yakobson A</searchLink>; The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Faehling+M%22">Faehling M</searchLink>; Department of Pneumology, Esslingen Hospital, Esslingen, Germany.<br /><searchLink fieldCode="AU" term="%22Kahala+D%22">Kahala D</searchLink>; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Sara+Granot+I%22">Sara Granot I</searchLink>; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Levitas+D%22">Levitas D</searchLink>; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Peled+N%22">Peled N</searchLink>; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Roisman+LC%22">Roisman LC</searchLink>; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2022 Sep 20; Vol. 12, pp. 1010311. <i>Date of Electronic Publication: </i>2022 Sep 20 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36203432 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2022.1010311 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1010311 Titles: – TitleFull: Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kian W – PersonEntity: Name: NameFull: Christopoulos P – PersonEntity: Name: NameFull: Remilah AA – PersonEntity: Name: NameFull: Levison E – PersonEntity: Name: NameFull: Dudnik E – PersonEntity: Name: NameFull: Shalata W – PersonEntity: Name: NameFull: Krayim B – PersonEntity: Name: NameFull: Marei R – PersonEntity: Name: NameFull: Yakobson A – PersonEntity: Name: NameFull: Faehling M – PersonEntity: Name: NameFull: Kahala D – PersonEntity: Name: NameFull: Sara Granot I – PersonEntity: Name: NameFull: Levitas D – PersonEntity: Name: NameFull: Peled N – PersonEntity: Name: NameFull: Roisman LC IsPartOfRelationships: – BibEntity: Dates: – D: 20 M: 09 Text: 2022 Sep 20 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 12 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |